We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Vascular Closure Device Seals Percutaneous Entry Point

By HospiMedica International staff writers
Posted on 24 Jul 2019
Print article
Image: The product line of the Celt ACD vascular closure devices (Photo courtesy of Vasorum).
Image: The product line of the Celt ACD vascular closure devices (Photo courtesy of Vasorum).
An innovative closure device seals arterial puncture holes following percutaneous coronary intervention (PCI) catheter-based vascular procedures.

The Vasorum (Dublin, Ireland) Celt ACD is designed to close a femoral arteriotomy following intra-arterial procedures, such as peripheral or coronary angiography, arterial stents, balloon angioplasty, and diagnostic or interventional catheterization procedures involving the common femoral artery. During the procedure, a proprietary biocompatible stainless steel implant--which is radiopaque and visible under fluoroscopic control during all phases of deployment and implantation--is applied to both the inside and the outside of the puncture site in the femoral artery at the level of the arterial wall.

Celt ACD is available pre-mounted to a 5F, 6F, or 7F delivery system, and does not require the user to exchange the existing procedural sheath before deployment. The device is contraindicated in patients with a femoral artery lumen diameter less than 5mm, patients with a known allergy to stainless steel, in severe, acute non-cardiac systemic disease or terminal illness with a life expectancy of less than one year, and in patients with systemic bacterial or cutaneous infection, active hematoma, arteriovenous fistula (AVF), pseudoaneurysm, or low platelet count.

“Celt ACD has proven itself to be a best in class arterial puncture closure device. The device allows immediate closure of multiple re-sticks in calcified vessels, and is also very comfortable for patients,” said Jim Coleman MD, co-founder, CEO, and clinical director of Vasorum, adding, “the device allows rapid and complete hemostasis independent of vascular anatomy, including calcified arteries.”

Vascular complications related to arterial access are common causes of morbidity, mortality, and cost in those undergoing PCI. Many strategies have been tried to decrease bleeding and vascular access site complications; vascular closure devices emerged as an effective alternative to traditional mechanical compression, as they can reduce time to hemostasis, facilitate early patient mobilization, reduce patient discomfort associated with prolonged bed rest, improve patient satisfaction, and reduce hospital length of stay.

Related Links:

Print article



view channel

Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio

Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.